CONTEXT:  Market report on the still buoyant RWE market, or at least the valuations of the market are buoyant | Different day, different figure

IMPACT:  Low

READ TIME:  1 min


Quality Level Mean [1 – 10]:  6

1. “Besides, the real-world data sets are widely adopted by end-users for RWE for various applications such as drug development & approvals, market access & reimbursement/coverage decisions, clinical decision-making, and medical device development & approvals, among others, that helps in the growth of the overall market.” 

2. “Based on the therapeutic area, the real-world evidence market is broadly categorized into oncology, immunology, neurology, cardiovascular disease, and other therapeutic areas the oncology segment has been accounted for the largest share of the real-world evidence market.” 

3. “Get Sample Copy of the Report landscape . Key players for Real World Evidence Solutions Market Anthem, Inc., Clinigen Group plc, Cognizant Technology Solutions Corporation, International Business Machines (IBM) Corporation, ICON Public Limited, Quintiles IMS Holdings, Inc., UnitedHealth Group, Oracle Corporation, PAREXEL International Corporation, PerkinElmer, Inc., and other Prominent Players.” 

4. “Scope of the Report . By value . Market share and forecast . By Therapeutic Area . Cardiovascular . Oncology . Immunology . Others . By Component . Dataset . Clinical Setting Data . Claims Data . Pharmacy . Patient Powered Data . Services . By End User . Medical Devices . Payers . Pharmaceuticals . Providers . By region . North America . Europe . APAC . Middle East and Africa . Latin America . The objective of the Study: . To estimate and forecast market size of Global Real-World Evidence Solutions market.” 

5. “To define, describe, forecast, and segment the Real-World Evidence Solutions market based on Therapeutic Area, Component and End User coupled with region.” 

Source URL: https://ksusentinel.com/2021/04/05/real-world-evidence-solution-market-is-projected-to-reach-the-valuation-of-usd-3321-7-million-by-2026-with-a-cagr-of-16-5/